MarketCap
Facebook
X
TelegramQuarterly report 2023-Q2
added 08-14-2023
Country |
 USA |
IPO year |
2014 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ CAPITAL |
Shares |
17 M |
Market Cap[1] |
$ 7.29 M |
EBITDA (LTM) |
$ -21.8 M |
P/E (LTM) |
- |
P/S (LTM) |
0.58 |
EPS (LTM) |
-22.06 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Interpace Biosciences
IDXG
|
$ 1.71 | 0.73 % | $ 7.5 M | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 124.98 | 0.52 % | $ 19.9 B | Nasdaq Global Select Market,SPB | USA |
 |
Biomerica
BMRA
|
$ 2.1 | -4.11 % | $ 4.82 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Brainsway Ltd.
BWAY
|
$ 13.78 | 0.88 % | $ 99.4 M | Nasdaq Global Select Market | Israel |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Lantheus Holdings
LNTH
|
$ 76.15 | -0.37 % | $ 5.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Fulgent Genetics
FLGT
|
$ 16.37 | 5.54 % | $ 495 M | Nasdaq Global Market | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Exact Sciences Corporation
EXAS
|
$ 104.91 | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 8.16 | 2.51 % | $ 1.05 B | Nasdaq Global Select Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
National Research Corporation
NRC
|
$ 17.59 | 1.56 % | $ 394 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 201.36 | 3.11 % | $ 19.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Co-Diagnostics
CODX
|
$ 4.4 | 101.83 % | $ 129 M | Nasdaq Capital Market | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
OPKO Health
OPK
|
$ 1.14 | 1.34 % | $ 791 M | Nasdaq Global Select Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Personalis
PSNL
|
$ 7.58 | 4.34 % | $ 449 M | Nasdaq Global Select Market | USA |
 |
Charles River Laboratories International
CRL
|
$ 158.0 | 2.92 % | $ 7.83 B | NYSE,SPB | USA |
 |
IQVIA Holdings
IQV
|
$ 168.41 | 1.4 % | $ 28.9 B | NYSE,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
IDEXX Laboratories
IDXX
|
$ 582.33 | 0.88 % | $ 46.8 B | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
BioNano Genomics
BNGO
|
$ 1.38 | 19.95 % | $ 1.75 M | Nasdaq Capital Market,SPB | USA |
 |
Medpace Holdings
MEDP
|
$ 459.17 | 1.47 % | $ 13.2 B | Nasdaq Global Select Market,SPB | USA |
 |
Senseonics Holdings
SENS
|
$ 6.63 | 2.31 % | $ 277 M | NYSE American | USA |
 |
Sotera Health Company
SHC
|
$ 13.96 | 3.37 % | $ 3.96 B | Nasdaq Global Select Market | USA |
 |
Agilent Technologies
A
|
$ 112.76 | 1.34 % | $ 34.3 B | NYSE,SPB | USA |
 |
ICON Public Limited Company
ICLR
|
$ 101.1 | 1.4 % | $ 8.34 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
DarioHealth Corp.
DRIO
|
$ 7.5 | -6.13 % | $ 29.9 M | Nasdaq Capital Market | Israel |
 |
Guardant Health
GH
|
$ 85.46 | 0.33 % | $ 10.7 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.68 | 2.18 % | $ 433 M | Nasdaq Global Select Market,SPB | USA |
 |
Soleno Therapeutics
SLNO
|
$ 32.26 | -2.89 % | $ 1.64 B | Nasdaq Capital Market | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Neuronetics
STIM
|
$ 1.61 | 10.69 % | $ 106 M | Nasdaq Global Select Market | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 246.21 | 3.5 % | $ 25.7 B | NYSE,SPB |  Schweiz |
 |
CareDx, Inc
CDNA
|
$ 17.63 | 2.8 % | $ 939 M | Nasdaq Global Market,SPB | USA |
 |
ENDRA Life Sciences
NDRA
|
$ 3.45 | - | $ 1.85 M | Nasdaq Global Select Market | USA |
 |
Celcuity
CELC
|
$ 106.93 | 0.84 % | $ 4.22 B | Nasdaq Global Select Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 266.3 | 1.22 % | $ 22.2 B | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.